MARIMED INC.— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$42M
↑+7.5% +$3Mvs FY2024 (Q4)
Gross Profit
$11M
↓-15.7% -$2Mvs FY2024 (Q4)
Operating Income
$8M
↓-18.1% -$2Mvs FY2024 (Q4)
Net Income
$6M
↑+81.4% +$3Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $42M | $39M |
| COGS | $31M | $26M |
| Gross Profit | $11M | $12M |
| R&D | $0 | $0 |
| SG&A | $0 | $0 |
| D&A | $2M | $2M |
| Other OpEx | $0 | $0 |
| Operating Income | $8M | $10M |
| Interest Exp. | $2M | $2M |
| Other Non-Op | $0 | $0 |
| Pretax Income | $6M | $8M |
| Tax | $0 | $5M |
| Net Income | $6M | $3M |
QuarterCharts · SEC EDGAR data · MRMD · Comparing FY2025 (Q4) vs FY2024 (Q4)